Jared A Greenberg1, Samuel F Hohmann2, Jesse B Hall3, John P Kress3, Michael Z David4. 1. 1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Rush University Medical Center, Chicago, Illinois. 2. 2 University HealthSystem Consortium, Oak Brook, Illinois. 3. 3 Section of Pulmonary and Critical Care Medicine, and. 4. 4 Section of Infectious Disease and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
Abstract
RATIONALE: Immunocompromised patients are at high risk for developing severe sepsis. Currently, there are no validated strategies for identifying this group of patients in large administrative databases. OBJECTIVES: We set out to define and validate a method that could be used to identify immunocompromised patients with severe sepsis in administrative databases. METHODS: Patients were categorized as immunocompromised based on the presence of International Classification of Diseases, 9th revision discharge diagnosis codes and medication data. We validated this strategy by comparing the discriminatory ability of the search algorithm to that of manual chart review. MEASUREMENTS AND MAIN RESULTS: We identified 4,438 patients at a single academic center with severe sepsis using a definition applied to administrative data described by Angus and colleagues. There were 1,185 (26.7%) who were categorized as immunocompromised based on our novel administrative data search strategy. Compared with identification by medical record review, the new administrative data search strategy had positive and negative predictive values of 94.4% (95% confidence interval [CI], 88.8-97.7%) and 94.3% (95% CI, 91.0-96.6%). The sensitivity and specificity were 87.4% (95% CI, 80.6-92.5%) and 97.6% (95% CI, 95.0-99.9%). CONCLUSIONS: Patients who are immunosuppressed are a large subgroup of those with severe sepsis. Following its validation as a search strategy using other large databases, and its adaptation for International Classification of Diseases, 10th revision, this novel method may allow researchers to account for a patient's immune state when examining outcomes.
RATIONALE: Immunocompromised patients are at high risk for developing severe sepsis. Currently, there are no validated strategies for identifying this group of patients in large administrative databases. OBJECTIVES: We set out to define and validate a method that could be used to identify immunocompromised patients with severe sepsis in administrative databases. METHODS:Patients were categorized as immunocompromised based on the presence of International Classification of Diseases, 9th revision discharge diagnosis codes and medication data. We validated this strategy by comparing the discriminatory ability of the search algorithm to that of manual chart review. MEASUREMENTS AND MAIN RESULTS: We identified 4,438 patients at a single academic center with severe sepsis using a definition applied to administrative data described by Angus and colleagues. There were 1,185 (26.7%) who were categorized as immunocompromised based on our novel administrative data search strategy. Compared with identification by medical record review, the new administrative data search strategy had positive and negative predictive values of 94.4% (95% confidence interval [CI], 88.8-97.7%) and 94.3% (95% CI, 91.0-96.6%). The sensitivity and specificity were 87.4% (95% CI, 80.6-92.5%) and 97.6% (95% CI, 95.0-99.9%). CONCLUSIONS:Patients who are immunosuppressed are a large subgroup of those with severe sepsis. Following its validation as a search strategy using other large databases, and its adaptation for International Classification of Diseases, 10th revision, this novel method may allow researchers to account for a patient's immune state when examining outcomes.
Entities:
Keywords:
administrative database; immunosuppression; severe sepsis
Authors: Jenneke Leentjens; Matthijs Kox; Johannes G van der Hoeven; Mihai G Netea; Peter Pickkers Journal: Am J Respir Crit Care Med Date: 2013-06-15 Impact factor: 21.405
Authors: Lorry G Rubin; Myron J Levin; Per Ljungman; E Graham Davies; Robin Avery; Marcie Tomblyn; Athos Bousvaros; Shireesha Dhanireddy; Lillian Sung; Harry Keyserling; Insoo Kang Journal: Clin Infect Dis Date: 2013-12-04 Impact factor: 9.079
Authors: Debra D Poutsiaka; Lisa E Davidson; Katherine L Kahn; David W Bates; David R Snydman; Patricia L Hibberd Journal: Scand J Infect Dis Date: 2009
Authors: Paula D Strassle; Emily E Sickbert-Bennett; Michael Klompas; Jennifer L Lund; Paul W Stewart; Ashley H Marx; Lauren M DiBiase; David J Weber Journal: Infect Control Hosp Epidemiol Date: 2019-10-29 Impact factor: 3.254
Authors: Jared A Greenberg; Samuel F Hohmann; Bryan D James; Raj C Shah; Jesse B Hall; John P Kress; Michael Z David Journal: Ann Am Thorac Soc Date: 2018-08
Authors: Andrew D Wiese; Marie R Griffin; C Michael Stein; William Schaffner; Robert A Greevy; Edward F Mitchel; Carlos G Grijalva Journal: BMJ Open Date: 2018-06-19 Impact factor: 2.692
Authors: Peter J Embi; Matthew E Levy; Allison L Naleway; Palak Patel; Manjusha Gaglani; Karthik Natarajan; Kristin Dascomb; Toan C Ong; Nicola P Klein; I-Chia Liao; Shaun J Grannis; Jungmi Han; Edward Stenehjem; Margaret M Dunne; Ned Lewis; Stephanie A Irving; Suchitra Rao; Charlene McEvoy; Catherine H Bozio; Kempapura Murthy; Brian E Dixon; Nancy Grisel; Duck-Hye Yang; Kristin Goddard; Anupam B Kharbanda; Sue Reynolds; Chandni Raiyani; William F Fadel; Julie Arndorfer; Elizabeth A Rowley; Bruce Fireman; Jill Ferdinands; Nimish R Valvi; Sarah W Ball; Ousseny Zerbo; Eric P Griggs; Patrick K Mitchell; Rachael M Porter; Salome A Kiduko; Lenee Blanton; Yan Zhuang; Andrea Steffens; Sarah E Reese; Natalie Olson; Jeremiah Williams; Monica Dickerson; Meredith McMorrow; Stephanie J Schrag; Jennifer R Verani; Alicia M Fry; Eduardo Azziz-Baumgartner; Michelle A Barron; Mark G Thompson; Malini B DeSilva Journal: MMWR Morb Mortal Wkly Rep Date: 2021-11-05 Impact factor: 17.586
Authors: Kailey Hughes; Donald B Middleton; Mary Patricia Nowalk; Goundappa K Balasubramani; Emily T Martin; Manjusha Gaglani; H Keipp Talbot; Manish M Patel; Jill M Ferdinands; Richard K Zimmerman; Fernanda P Silveira Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Jared A Greenberg; Cara L Hrusch; Mohammad R Jaffery; Michael Z David; Robert S Daum; Jesse B Hall; John P Kress; Anne I Sperling; Philip A Verhoef Journal: Crit Care Date: 2018-04-25 Impact factor: 9.097